Noubar Afeyan
Pioneering innovations and institutional entrepreneurship to tackle challenges in health and sustainability@ Flagship Pioneering
Cambridge, Massachusetts, United States
View Noubar Afeyan's Email
View Noubar Afeyan's Email & Phone
Real-Time AI Research
0 search queries left
FlashIntel GPT
Hello! I'm FlashIntel GPT, your personal AI search assistant. Feel free to ask me anything about Noubar Afeyan, and I'll do my best to assist you.
You

Tell me more about Noubar Afeyan?

FlashIntel GPT

Noubar Afeyan is a highly experienced professional with 34.9 years of work experience in venture capital, start-ups, entrepreneurship, biotechnology, and lifesciences. Based in the United States, Noubar has a strong background in Flagship Pioneering, a company that transforms human health and sustainability. With a team of 41 transformative companies, including Denali Therapeutics, Evelo Biosciences, Foghorn Therapeutics, Moderna, Omega Therapeutics, and Seres Therapeutics, Noubar has played a key role in the founding and growth of pioneering companies.
For inquiries about Phone Number and Email, please click here Unlock Contact

Research Details
Skills & Insights
Colleagues

Emails and Phone Numbers

@flagshipventures.com
@mit.edu
@alltrna.com
@omegatherapeutics.com
@tesseratherapeutics.com
@generatebiomedicines.com
@indigo.ca
@hbs.edu
@auroraprize.com
@hotmail.com
@ensembletx.com
@tesseratx.com
@rubiustx.com
@profoundtx.com
+1 617714****
+1 781890****
+1 617218****
+1 617868****
+1 781533****
View Emails and Phone Numbers
10 free lookups per month

About

Flagship Pioneering conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability. Since its launch in 2000, the firm has, through its Flagship Labs unit, applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in more than $100 billion in aggregate value. To date, Flagship has deployed over $2.9 billion in capital toward the founding and growth of its pioneering companies alongside more than $19 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Foghorn Therapeutics (NASDAQ: FHTX), Moderna (NASDAQ: MRNA), Omega Therapeutics (NASDAQ: OMGA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology (NASDAQ: SANA), and Seres Therapeutics (NASDAQ: MCRB).To learn more about Flagship Pioneering, please visit our website: www.FlagshipPioneering.com.

...See More

Work Experience

55 Cambridge Parkway, Cambridge, MA, 02142, US

Biotechnology Research

535
Show More

Noubar Afeyan's Professional Milestones

  • Board Member | Co-Founder (2003-01-01~2011-01-01): Secured exclusive executive contracts, driving business growth and gaining international recognition.
  • Co-Founder (2002-01-01~2020-03-01): Established a successful startup from the ground up, establishing the company as a leader in that industry.
Show More

Education

Massachusetts Institute of Technology
Massachusetts Institute of Technology

Biochemical Engineering,

Ph.d.

1983-1987
Show More